Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia

Abstract Background The main advantage of GeneXpert MTB/RIF® (Xpert) molecular diagnostic technology is the rapid detection of M.tuberculosis DNA and mutations associated with rifampicin (RIF) resistance for timely initiation of appropriate treatment and, consequently, preventing further transmissio...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Julia V. Ershova, Grigory V. Volchenkov, Tatiana R. Somova, Tatiana A. Kuznetsova, Natalia V. Kaunetis, Dorothy Kaminski, Olga V. Demikhova, Larisa N. Chernousova, Irina A. Vasilyeva, Eleanor M. Kerr, J. Peter Cegielski, Ekaterina V. Kurbatova
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2020-07-01
coleção:	BMC Infectious Diseases
Assuntos:	Drug resistance Rifampicin GeneXpert MTB/RIF
Acesso em linha:	http://link.springer.com/article/10.1186/s12879-020-05243-9
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!